Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier. - Puchongmart C; Rodriguez CC; Soliman D; Shotelersuk V; Sivakumar N; Yanpiset P; Thiravetyan B; Leelaviwat N; Sly Z (Journal of cardiovascular pharmacology, 2026)